Amphotericin B liposome (Ginposome Pharmaceutical)
两性霉素B脂质体（本素药业）
Report date: 2026/03/04 20:01:44
Base Information
Drug NameAmphotericin B liposome (Ginposome Pharmaceutical)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesXiamen Ginposome Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesXiamen Ginposome Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A